Nonconserved miR‐608 suppresses prostate cancer progression through RAC2/PAK4/LIMK1 and BCL2L1/caspase‐3 pathways by targeting the 3′‐UTRs of RAC2/BCL2L1 and the coding region of PAK4

The aim of this study is to investigate the functions and mechanisms of miR‐608 in prostate cancer (PCa). CISH and qRT‐PCR analysis demonstrated that miR‐608 was low expressed in PCa tissues and cells, which was partly attributed to the methylation of CpG island adjacent to the transcription start s...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xu, Fang, Jiajie, Chen, Shiming, Wang, Weiyu, Meng, Shuai, Liu, Ben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746107/
https://www.ncbi.nlm.nih.gov/pubmed/31389670
http://dx.doi.org/10.1002/cam4.2455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746107/
https://www.ncbi.nlm.nih.gov/pubmed/31389670
http://dx.doi.org/10.1002/cam4.2455

Ejemplares similares